Peptide homing to brain tumors

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/08 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2723887

The present invention relates to a peptide, which specifically homes to the intracranial, early stage astrocytoma model that grows as islets and harbors co-opted tumor vessels in the brain. The peptide finds its use in targeted delivery of therapeutic substances to invasive brain cancer or metastatic brain lesions as such and in combination with conventional therapies, such as surgery and radiation, and anti-angiogenic therapies, and as a tool in diagnosis of, e.g., invasive brain cancer or metastatic brain lesions.

L'invention porte sur un peptide qui migre spécifiquement vers le modèle intracrânien du stade précoce d'astrocytome qui se développe dans le cerveau sous la forme d'îlots renfermant des vaisseaux tumoraux. Ledit peptide trouve son utilisation dans l'administration ciblée de substances thérapeutiques à des cancers du cerveau invasifs ou à des lésions cérébrales métastatiques, seul ou en association avec des thérapies conventionnelles, telles que la chirurgie et la radiothérapie et des thérapies antiangiogéniques, et comme outil diagnostique, par exemple pour le cancer du cerveau invasif ou les lésions cérébrales métastatiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide homing to brain tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide homing to brain tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide homing to brain tumors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1927016

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.